$322.28

-3.03 (-0.93%)

Weekly Expected Move ±4.0%

$296 $309 $322 $335 $348

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $9.5B mcap · 24M float · 1.56% daily turnover · Short 75% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

56.5 / 100

NoneWeakNarrowWide

Primary source: Switching Costs · ROIC: 40.4% · 5Y Avg: 1984.4%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. KRYS has a Narrow competitive edge (56.5/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. ROIC of 40.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$400

Low

$420

Avg Target

$441

High

Based on 2 analysts since Aug 3, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 17Hold: 0Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$438.33

Analysts3

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-09-24	Goldman Sachs	Andrea Newkirk	$327	$441	+114	+29.0%	$341.75
2026-08-14	RBC Capital	Lisa Walter	Initiated	$400	—	+21.8%	$328.34
2026-07-13	Jefferies	—	$371	$474	+103	+32.2%	$358.52
2026-06-16	H.C. Wainwright	Joseph Pantginis	$310	$361	+51	+11.8%	$323.00
2026-05-05	Evercore ISI	—	$206	$300	+94	+2.0%	$294.07
2026-02-18	Chardan Capital	Geulah Livshits	$216	$323	+107	+14.3%	$282.65
2026-02-17	Jefferies	Roger Song	Initiated	$371	—	+27.4%	$291.10
2026-01-30	Goldman Sachs	—	Initiated	$327	—	+17.1%	$279.34
2026-01-09	H.C. Wainwright	—	Initiated	$310	—	+24.5%	$248.91
2025-10-17	Guggenheim	Debjit Chattopadhyay	Initiated	$224	—	+18.9%	$188.33
2025-08-22	Chardan Capital	—	$133	$216	+83	+43.5%	$150.49
2024-09-11	Stifel Nicolaus	Dae Gon Ha	$204	$220	+16	+18.9%	$185.00
2024-09-02	Bank of America Securities	Alec Stranahan	Initiated	$205	—	+5.1%	$195.12
2024-08-12	Evercore ISI	Gavin Clark-Gartner	Initiated	$206	—	+13.1%	$182.17
2024-04-15	Stifel Nicolaus	Dae Gon Ha	Initiated	$204	—	+20.2%	$169.75
2022-11-07	Chardan Capital	Geulah Livshits	$130	$133	+3	+70.4%	$78.05
2022-08-08	Chardan Capital	Geulah Livshits	Initiated	$130	—	+57.8%	$82.40

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KRYS receives an overall rating of B. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-10-01	A-	B
2026-08-28	B+	A-
2026-08-03	A-	B+
2026-05-04	B+	A-
2026-04-01	A-	B+
2026-03-09	B+	A-
2026-03-02	A-	B+
2026-02-18	C+	A-
2026-02-17	A-	C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 84 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. KRYS scores highest in Safety (100/100) and lowest in Value (32/100). An overall grade of A+ places KRYS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

49.94

Safe Zone

Piotroski F-Score

7/9

✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓

Beneish M-Score

-2.06

Unlikely Manipulator

Ohlson O-Score

-14.26

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA+

Score: 94.7/100

Trend: Stable

Earnings Quality

100/100

OCF/NI: 1.13x

Accruals: -2.3%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. KRYS scores 49.94, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KRYS scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. KRYS's score of -2.06 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KRYS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KRYS receives an estimated rating of AA+ (score: 94.7/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). KRYS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

38.97x

PEG

0.63x

P/S

21.57x

P/B

7.00x

P/FCF

44.20x

P/OCF

41.84x

EV/EBITDA

48.33x

EV/Revenue

23.97x

EV/EBIT

49.49x

EV/FCF

40.96x

Earnings Yield

2.12%

FCF Yield

2.26%

Shareholder Yield

0.15%

Graham Number

$88.64

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 39.0x earnings, KRYS commands a growth premium. Graham's intrinsic value formula yields $88.64 per share, 264% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.066

NI / EBT

Interest Burden

1.062

EBT / EBIT

EBIT Margin

0.484

EBIT / Rev

Asset Turnover

0.334

Rev / Assets

Equity Multiplier

1.100

Assets / Equity

ROE

20.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KRYS's ROE of 20.1% is driven by EBIT Margin (0.484) as the dominant factor. A tax burden ratio of 1.07 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$303.24

Price/Value

1.23x

Margin of Safety

-22.57%

Premium

22.57%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with KRYS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. KRYS trades at a 23% premium to its adjusted intrinsic value of $303.24, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 39.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$322.28

Median 1Y

$347.18

5th Pctile

$110.04

95th Pctile

$1099.98

Ann. Volatility

64.5%

Analyst Target

$438.33

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Krish S. Krishnan Chair and Chief Executive Officer	$846,167	$4,104,825	$10,442,485
Suma M. Krishnan President, R&D	$677,500	$2,868,000	$6,948,401
Kathryn A. Romano Chief Accounting Officer	$437,500	$394,350	$2,258,697

CEO Pay Ratio

21:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $10,442,485

Avg Employee Cost (SGA/emp): $497,427

Employees: 295

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

295

+7.3% YoY

Revenue / Employee

$1,319,085

Rev: $389,130,000

Profit / Employee

$694,342

NI: $204,831,000

SGA / Employee

$497,427

Avg labor cost proxy

R&D / Employee

$196,763

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-16.4%	-15.7%	-21.2%	-23.6%	-27.3%	-25.1%	-26.1%	-23.2%	-4.6%	1.7%	8.9%	14.2%	6.4%	10.3%	13.9%	15.6%	19.7%	18.9%	19.9%	20.1%	20.12%
ROA	-15.3%	-14.8%	-19.6%	-22.1%	-25.3%	-23.6%	-23.6%	-21.8%	-4.4%	1.6%	8.3%	13.2%	5.9%	9.5%	12.9%	14.3%	17.9%	17.1%	18.2%	18.3%	18.30%
ROIC	-61.3%	-33.0%	-50.7%	-50.6%	-54.5%	-62.5%	-76.8%	-65.7%	-57.7%	-36.5%	-24.3%	-7.1%	8.2%	17.2%	25.8%	32.9%	40.4%	43.5%	42.0%	40.4%	40.37%
ROCE	-13.7%	-11.3%	-18.6%	-20.5%	-24.1%	-26.9%	-25.9%	-20.9%	-17.4%	-11.4%	-5.9%	1.4%	8.1%	10.8%	13.4%	14.4%	14.3%	13.1%	14.5%	15.5%	15.53%
Gross Margin	—	—	—	—	—	—	—	—	97.4%	89.6%	94.7%	91.5%	92.0%	94.6%	94.3%	92.5%	94.2%	89.8%	94.6%	94.6%	94.60%
Operating Margin	—	—	—	—	—	—	—	—	-3.0%	7.4%	-14.8%	12.2%	26.8%	45.4%	41.0%	40.9%	42.3%	41.5%	46.1%	49.0%	49.00%
Net Margin	—	—	—	—	—	—	—	—	9.4%	20.6%	2.1%	22.2%	32.4%	49.9%	40.5%	39.9%	81.2%	48.0%	48.1%	45.9%	45.94%
EBITDA Margin	—	—	—	—	—	—	—	—	-2.9%	28.9%	16.4%	32.8%	43.5%	47.1%	42.9%	42.5%	50.7%	37.0%	54.3%	55.4%	55.43%
FCF Margin	—	—	—	—	—	—	—	—	-13.9%	-2.0%	-56.7%	-13.7%	24.0%	41.0%	38.8%	51.6%	44.4%	48.5%	56.9%	58.5%	58.52%
OCF Margin	—	—	—	—	—	—	—	—	-12.1%	-1.8%	-48.7%	-10.1%	26.2%	42.5%	41.5%	54.4%	47.2%	51.6%	60.0%	61.8%	61.83%
ROE 3Y Avg	snapshot only																				14.83%
ROE 5Y Avg	snapshot only																				0.47%
ROA 3Y Avg	snapshot only																				13.51%
ROIC 3Y Avg	snapshot only																				34.81%
ROIC Economic	snapshot only																				15.52%
Cash ROA	snapshot only																				18.15%
Cash ROIC	snapshot only																				52.14%
CROIC	snapshot only																				49.35%
NOPAT Margin	snapshot only																				47.88%
Pretax Margin	snapshot only																				51.45%
R&D / Revenue	snapshot only																				13.45%
SGA / Revenue	snapshot only																				36.26%
SBC / Revenue	snapshot only																				9.43%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-19.94	-22.33	-16.11	-14.53	-13.76	-14.46	-15.21	-22.29	-112.42	327.03	91.18	51.37	103.93	52.51	43.45	27.87	26.48	36.05	35.02	47.19	38.970
P/S Ratio	—	—	—	—	—	—	—	—	391.71	70.52	54.32	32.74	22.54	16.11	16.15	11.38	14.11	18.98	18.88	25.87	21.569
P/B Ratio	2.84	2.62	3.05	3.00	3.30	3.88	4.20	4.79	4.43	4.59	6.52	6.49	6.14	4.95	5.47	3.93	4.63	6.05	6.17	8.38	7.002
P/FCF	-16.63	-13.36	-12.21	-9.20	-9.51	-13.18	-13.51	-24.11	-28.15	-35.54	-95.74	-239.16	93.75	39.28	41.65	22.05	31.80	39.09	33.20	44.20	44.201
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	85.93	37.93	38.89	20.93	29.89	36.76	31.49	41.84	41.839
EV/EBITDA	-15.21	-17.20	-12.40	-11.20	-10.92	-11.97	-13.82	-20.00	-22.00	-36.30	-112.51	270.98	61.44	37.22	34.06	21.62	26.55	39.12	36.57	48.33	48.333
EV/Revenue	—	—	—	—	—	—	—	—	326.99	60.18	48.79	29.42	20.13	14.08	14.33	9.51	12.18	16.87	16.93	23.97	23.968
EV/EBIT	-14.55	-16.50	-12.01	-10.86	-10.61	-11.63	-13.35	-19.30	-21.13	-34.01	-98.41	423.58	67.09	39.65	35.78	22.51	27.57	40.71	37.88	49.49	49.489
EV/FCF	-11.83	-9.66	-9.10	-6.92	-7.46	-10.77	-11.27	-20.50	-23.50	-30.33	-85.99	-214.91	83.74	34.33	36.95	18.43	27.45	34.75	29.77	40.96	40.955
Earnings Yield	-5.0%	-4.5%	-6.2%	-6.9%	-7.3%	-6.9%	-6.6%	-4.5%	-0.9%	0.3%	1.1%	1.9%	1.0%	1.9%	2.3%	3.6%	3.8%	2.8%	2.9%	2.1%	2.12%
FCF Yield	-6.0%	-7.5%	-8.2%	-10.9%	-10.5%	-7.6%	-7.4%	-4.1%	-3.6%	-2.8%	-1.0%	-0.4%	1.1%	2.5%	2.4%	4.5%	3.1%	2.6%	3.0%	2.3%	2.26%
PEG Ratio	snapshot only																				0.627
Price/Tangible Book	snapshot only																				8.384
EV/OCF	snapshot only																				38.766
EV/Gross Profit	snapshot only																				25.678
Acquirers Multiple	snapshot only																				53.343
Shareholder Yield	snapshot only																				0.15%
Graham Number	snapshot only																				$88.64

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	9.67	17.18	7.25	12.45	14.18	13.30	10.13	20.25	21.10	17.76	12.66	9.50	7.97	7.28	9.65	9.68	10.14	9.95	9.46	8.32	8.318
Quick Ratio	9.67	17.18	7.25	12.45	14.18	13.30	10.13	20.25	20.91	17.55	12.42	9.33	7.76	7.02	9.27	9.33	9.73	9.56	9.06	7.96	7.960
Debt/Equity	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.007
Net Debt/Equity	-0.82	-0.72	-0.78	-0.74	-0.71	-0.71	-0.70	-0.72	-0.73	-0.67	-0.66	-0.66	-0.66	-0.62	-0.62	-0.65	-0.63	-0.67	-0.64	-0.62	-0.616
Debt/Assets	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.006
Debt/EBITDA	-0.15	-0.12	-0.09	-0.08	-0.07	-0.06	-0.07	-0.06	-0.07	-0.10	-0.19	0.43	0.09	0.07	0.07	0.06	0.06	0.06	0.05	0.04	0.041
Net Debt/EBITDA	6.18	6.59	4.23	3.70	3.00	2.68	2.75	3.53	4.35	6.24	12.75	-30.58	-7.34	-5.37	-4.33	-4.25	-4.22	-4.88	-4.21	-3.83	-3.831
Interest Coverage	-38.00	-45.63	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.10	1.06	1.12	1.08	1.07	1.07	1.09	1.05	1.05	1.05	1.07	1.09	1.11	1.12	1.09	1.09	1.09	1.09	1.09	1.10	1.104
Cash Ratio	snapshot only																				6.638
Cash to Debt	snapshot only																				95.519
FCF to Debt	snapshot only																				29.118
Defensive Interval	snapshot only																				1684.9 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.07	0.14	0.21	0.27	0.31	0.35	0.35	0.34	0.33	0.34	0.33	0.334
Inventory Turnover	—	—	—	—	—	—	—	—	0.08	1.32	1.27	2.14	1.63	1.20	1.11	1.10	0.81	0.86	0.83	0.77	0.766
Receivables Turnover	—	—	—	—	—	—	—	—	1.84	2.41	4.13	3.22	4.53	3.96	4.45	3.35	3.29	3.35	3.62	3.52	3.522
Payables Turnover	0.00	0.00	0.20	0.19	0.19	0.16	0.00	0.00	0.04	1.58	1.48	2.64	3.93	5.87	5.65	3.80	5.94	7.00	8.89	4.29	4.293
DSO	—	—	—	—	—	—	—	—	199	151	88	113	81	92	82	109	111	109	101	104	103.6 days
DIO	—	—	0	0	0	0	—	—	4319	277	287	171	223	305	330	331	450	425	441	476	476.4 days
DPO	—	—	1808	1887	1891	2226	—	—	8267	231	246	138	93	62	65	96	61	52	41	85	85.0 days
Cash Conversion Cycle	—	—	—	—	—	—	—	—	-3748	197	129	146	211	335	347	344	499	482	500	495	495.1 days
Fixed Asset Turnover	snapshot only																				2.743
Operating Cycle	snapshot only																				580.1 days
Cash Velocity	snapshot only																				0.521
Capital Intensity	snapshot only																				3.407

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	—	—	—	—	—	—	—	—	—	—	—	—	27.2%	4.7%	2.5%	1.2%	54.5%	33.9%	25.1%	22.6%	22.63%
Net Income	-1.1%	-1.2%	-1.4%	-1.2%	-1.2%	-1.0%	-30.5%	-21.6%	77.0%	1.1%	1.4%	1.8%	2.8%	7.2%	1.2%	38.5%	2.8%	1.3%	81.5%	64.6%	64.57%
EPS	-89.8%	-95.0%	-1.1%	-92.4%	-93.4%	-74.8%	-27.4%	-16.5%	79.6%	1.1%	1.4%	1.7%	2.7%	6.9%	1.1%	38.0%	2.8%	1.3%	77.7%	59.7%	59.70%
FCF	-99.1%	-1.8%	-2.0%	-2.5%	-1.7%	-32.1%	-11.4%	28.8%	36.6%	34.5%	64.3%	82.5%	1.5%	2.2%	3.4%	9.1%	1.9%	58.5%	83.6%	39.0%	39.01%
EBITDA	-1.1%	-1.2%	-1.6%	-1.3%	-1.4%	-1.1%	-23.6%	-18.2%	0.8%	39.2%	66.5%	1.1%	1.6%	2.3%	4.4%	7.8%	1.2%	52.7%	37.7%	38.2%	38.20%
Op. Income	-97.7%	-1.1%	-91.1%	-80.0%	-88.9%	-76.1%	-81.7%	-67.3%	-37.6%	8.7%	53.0%	86.3%	1.2%	1.6%	2.6%	7.6%	4.8%	1.5%	64.7%	42.1%	42.08%
OCF Growth	snapshot only																				39.38%
Asset Growth	snapshot only																				31.82%
Equity Growth	snapshot only																				30.60%
Debt Growth	snapshot only																				-8.55%
Shares Change	snapshot only																				3.05%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue 5Y	—	—	—	—	—	—	—	—	75.3%	1.0%	1.2%	1.3%	1.6%	2.0%	2.6%	—	—	—	—	—	—
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 5Y	—	—	—	—	—	—	—	—	74.4%	97.2%	1.1%	1.3%	1.5%	2.0%	2.6%	—	—	—	—	—	—
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets 3Y	1.0%	75.4%	74.7%	43.1%	39.1%	38.8%	37.4%	29.1%	36.4%	38.1%	24.4%	27.4%	29.6%	19.0%	20.3%	23.7%	29.1%	33.7%	38.0%	29.9%	29.94%
Assets 5Y	—	—	—	—	61.4%	62.0%	61.9%	71.6%	70.7%	47.8%	49.1%	34.9%	35.6%	38.3%	39.3%	29.0%	31.8%	33.8%	25.8%	27.6%	27.60%
Equity 3Y	98.4%	73.7%	71.1%	41.3%	37.6%	37.0%	35.1%	28.2%	35.8%	38.7%	22.9%	26.1%	29.5%	16.8%	21.5%	23.0%	28.1%	32.7%	37.6%	27.7%	27.67%
Book Value 3Y	55.1%	47.4%	42.2%	17.0%	20.7%	20.4%	18.6%	13.3%	19.5%	22.8%	10.4%	14.5%	17.2%	5.8%	14.7%	16.9%	21.8%	25.8%	30.0%	21.9%	21.86%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.22	0.89	0.80	0.60	0.05	0.05	0.19	0.66	0.36	0.38	0.39	0.40	0.42	0.52	0.58	0.65	0.70	0.76	0.80	0.85	0.846
Earnings Stability	0.86	0.84	0.79	0.80	0.77	0.80	0.87	0.88	0.32	0.08	0.00	0.01	0.06	0.17	0.29	0.35	0.54	0.63	0.72	0.74	0.738
Margin Stability	—	—	—	—	—	—	—	—	—	—	—	—	0.96	0.95	0.96	—	0.97	0.99	1.00	0.99	0.993
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0
Earnings Persistence	0.50	0.50	0.50	0.50	0.50	0.50	0.88	0.91	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00	0.26	0.68	0.00	0.21	0.42	0.51	0.512
ROE Trend	-0.06	-0.02	-0.09	-0.11	-0.12	-0.15	-0.13	-0.05	0.15	0.21	0.30	0.34	0.20	0.22	0.23	0.19	0.16	0.11	0.08	0.04	0.044
Gross Margin Trend	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.01	0.01	-0.00	0.01	0.006
FCF Margin Trend	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.28	1.27	0.66	0.40	0.396
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	1.7%	8.9%	14.2%	6.4%	10.3%	13.9%	15.6%	19.7%	18.9%	19.9%	20.1%	20.12%
Internal Growth Rate	—	—	—	—	—	—	—	—	—	1.6%	9.0%	15.2%	6.3%	10.5%	14.8%	16.6%	21.8%	20.7%	22.3%	22.4%	22.40%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.60	0.69	0.52	0.75	0.76	0.72	0.82	0.73	3.49	-8.12	-0.82	-0.16	1.21	1.38	1.12	1.33	0.89	0.98	1.11	1.13	1.128
FCF/OCF	1.99	2.43	2.54	2.10	1.89	1.53	1.37	1.27	1.15	1.13	1.16	1.36	0.92	0.97	0.93	0.95	0.94	0.94	0.95	0.95	0.947
FCF/Net Income	snapshot only																				1.068
OCF/EBITDA	snapshot only																				1.247
CapEx/Revenue	—	—	—	—	—	—	—	—	1.8%	23.3%	8.0%	3.6%	2.2%	1.5%	2.8%	2.8%	2.8%	3.1%	3.1%	3.3%	3.30%
CapEx/Depreciation	snapshot only																				2.854
Accruals Ratio	-0.06	-0.05	-0.09	-0.06	-0.06	-0.07	-0.04	-0.06	0.11	0.14	0.15	0.15	-0.01	-0.04	-0.02	-0.05	0.02	0.00	-0.02	-0.02	-0.023
Sloan Accruals	snapshot only																				0.131
Cash Flow Adequacy	snapshot only																				18.710
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	7.5%	7.1%	7.07%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.1%	0.15%
Net Buyback Yield	-13.3%	-22.9%	-12.2%	-14.0%	-13.2%	-1.8%	-1.9%	-6.2%	-5.7%	-5.3%	-3.6%	-0.0%	-0.0%	0.0%	0.0%	-0.0%	-0.1%	-0.3%	-0.1%	-0.2%	-0.21%
Total Shareholder Return	-13.3%	-22.9%	-12.2%	-14.0%	-13.2%	-1.8%	-1.9%	-6.2%	-5.7%	-5.3%	-3.6%	-0.0%	-0.0%	0.0%	0.0%	-0.0%	-0.1%	-0.3%	-0.1%	-0.2%	-0.21%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.85	0.97	0.98	0.91	0.94	0.90	0.87	1.06	1.08	1.09	1.07	1.066
Interest Burden (EBT/EBIT)	1.03	1.02	1.00	0.99	0.98	0.98	1.05	1.02	0.23	-0.14	-1.24	9.39	0.79	0.92	1.03	1.11	1.13	1.17	1.11	1.06	1.062
EBIT Margin	—	—	—	—	—	—	—	—	-15.48	-1.77	-0.50	0.07	0.30	0.36	0.40	0.42	0.44	0.41	0.45	0.48	0.484
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.07	0.14	0.21	0.27	0.31	0.35	0.35	0.34	0.33	0.34	0.33	0.334
Equity Multiplier	1.07	1.06	1.08	1.07	1.08	1.06	1.11	1.06	1.05	1.06	1.07	1.07	1.08	1.09	1.08	1.09	1.10	1.10	1.09	1.10	1.100

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-2.62	$-3.13	$-4.13	$-4.52	$-5.06	$-5.48	$-5.26	$-5.27	$-1.03	$0.38	$1.95	$3.57	$1.75	$2.98	$4.15	$4.93	$6.67	$6.84	$7.38	$7.88	$7.88
Book Value/Share	$18.38	$26.73	$21.84	$21.89	$21.11	$20.44	$19.04	$24.50	$26.16	$27.02	$27.29	$28.31	$29.62	$31.67	$32.96	$34.98	$38.14	$40.72	$41.85	$44.33	$46.03
Tangible Book/Share	$18.38	$26.73	$21.84	$21.89	$21.11	$20.44	$19.04	$24.50	$26.16	$27.02	$27.29	$28.31	$29.62	$31.67	$32.96	$34.98	$38.14	$40.72	$41.85	$44.33	$44.33
Revenue/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.30	$1.76	$3.28	$5.61	$8.08	$9.72	$11.16	$12.07	$12.51	$12.99	$13.68	$14.37	$14.92
FCF/Share	$-3.14	$-5.24	$-5.45	$-7.14	$-7.33	$-6.01	$-5.93	$-4.87	$-4.12	$-3.49	$-1.86	$-0.77	$1.94	$3.99	$4.33	$6.23	$5.55	$6.31	$7.78	$8.41	$8.73
OCF/Share	$-1.58	$-2.16	$-2.14	$-3.39	$-3.87	$-3.94	$-4.33	$-3.84	$-3.60	$-3.08	$-1.60	$-0.56	$2.12	$4.13	$4.64	$6.57	$5.91	$6.71	$8.20	$8.88	$9.22
Cash/Share	$15.45	$19.73	$17.31	$16.66	$15.40	$14.84	$13.63	$17.91	$19.45	$18.47	$18.38	$18.88	$19.68	$20.00	$20.65	$22.92	$24.51	$27.64	$26.99	$27.58	$28.64
EBITDA/Share	$-2.44	$-2.94	$-4.00	$-4.41	$-5.01	$-5.41	$-4.83	$-4.99	$-4.40	$-2.92	$-1.42	$0.61	$2.65	$3.68	$4.70	$5.31	$5.74	$5.60	$6.33	$7.13	$7.13
Debt/Share	$0.36	$0.36	$0.37	$0.36	$0.36	$0.35	$0.34	$0.32	$0.29	$0.28	$0.27	$0.26	$0.25	$0.24	$0.32	$0.33	$0.32	$0.31	$0.30	$0.29	$0.29
Net Debt/Share	$-15.08	$-19.37	$-16.94	$-16.30	$-15.04	$-14.49	$-13.29	$-17.59	$-19.17	$-18.19	$-18.11	$-18.62	$-19.43	$-19.75	$-20.33	$-22.60	$-24.19	$-27.33	$-26.69	$-27.29	$-27.29

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	49.941
Altman Z-Prime	snapshot only																				89.862
Piotroski F-Score	1	2	1	2	3	1	2	3	4	5	5	4	6	7	6	7	7	5	7	7	7
Beneish M-Score	—	—	—	—	—	—	—	—	—	—	—	—	6.15	-0.98	-1.27	-2.23	-2.01	-2.29	-2.21	-2.06	-2.062
Ohlson O-Score	snapshot only																				-14.260
ROIC (Greenblatt)	snapshot only																				19.52%
Net-Net WC	snapshot only																				$29.95
EVA	snapshot only																				$158646977.45

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA+
Credit Score	59.46	61.07	74.73	75.63	75.61	76.88	75.99	76.11	76.22	76.56	76.19	76.32	94.35	94.69	94.60	94.55	94.31	94.49	94.37	94.72	94.721
Credit Grade	snapshot only																				2
Credit Trend	snapshot only																				0.169
Implied Spread (bps)	snapshot only																				65.000
Industry Credit Rank	snapshot only																				94
Sector Credit Rank	snapshot only																				90

KRYS NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet